Evidence map›Paper›PMID 26010407›Full record

ArticleTraffic (Copenhagen, Denmark)2015

GSK-3β Phosphorylation of Cytoplasmic Dynein Reduces Ndel1 Binding to Intermediate Chains and Alters Dynein Motility.

Feng J Gao, Sachin Hebbar, Xu A Gao, Michael Alexander, Jai P Pandey, Michael D Walla, William E Cotham, Stephen J King, Deanna S Smith

Open access · hybridAbstract read
In one paragraph

Article in Traffic (Copenhagen, Denmark), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Disruption of axonal transport in neurodegeneration.The Journal of clinical investigation · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Disordered Expression ofInternational journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Feng J GaoDepartment of Biological Sciences, University of South Carolina, Columbia, SC, 29208, USA.
Sachin HebbarBioinformatics Group, Immune Tolerance Network, Bethesda, MD, 20814, USA.
Xu A GaoDepartment of Biological Sciences, University of South Carolina, Columbia, SC, 29208, USA.
Michael AlexanderDepartment of Biological Sciences, University of South Carolina, Columbia, SC, 29208, USA.
Jai P PandeyWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA.
Michael D WallaMass Spectrometry Center, Department of Chemistry & Biochemistry, University of South Carolina, Columbia, SC, 29208, USA.
William E CothamMass Spectrometry Center, Department of Chemistry & Biochemistry, University of South Carolina, Columbia, SC, 29208, USA.
Stephen J KingBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, 32828, USA.
Deanna S SmithDepartment of Biological Sciences, University of South Carolina, Columbia, SC, 29208, USA.
University of South Carolina · USImmune Tolerance Network · USMassachusetts Institute of Technology · USUniversity of Central Florida · US

Funding

TISSUE BIOREPOSITORYP20RR017698 · NCRR · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FAYAD, RAJA · 2002 to 2011
$22.5M
TISSUE BIOREPOSITORY COREP30GM103336 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BERGER, FRANKLIN G. · 2013 to 2017
$5.4M
Dynactin/microtubule interactions in dynein motilityR01NS048501 · NINDS · UNIVERSITY OF MISSOURI KANSAS CITY · PI KING, STEPHEN J · 2004 to 2014
$2.9M
Examining the role of the Lissencephaly Protein, Lis1, in Dynein-Based TransportR01NS056314 · NINDS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI SMITH, DEANNA S · 2008 to 2017
$2.5M
NCRR NIH HHS DSS-5P20RR017698NCRR NIH HHS P20 RR017698NIGMS NIH HHS P30 GM103336NINDS NIH HHS NS05631NINDS NIH HHS R01 NS048501NINDS NIH HHS R01 NS056314NINDS NIH HHS SJK-NS048501
6 · The paper itself

Abstract

Glycogen synthase kinase 3 (GSK-3) has been linked to regulation of kinesin-dependent axonal transport in squid and flies, and to indirect regulation of cytoplasmic dynein. We have now found evidence for direct regulation of dynein by mammalian GSK-3β in both neurons and non-neuronal cells. GSK-3β coprecipitates with and phosphorylates mammalian dynein. Phosphorylation of dynein intermediate chain (IC) reduces its interaction with Ndel1, a protein that contributes to dynein force generation. Two conserved residues, S87/T88 in IC-1B and S88/T89 in IC-2C, have been identified as GSK-3 targets by both mass spectrometry and site-directed mutagenesis. These sites are within an Ndel1-binding domain, and mutation of both sites alters the interaction of IC's with Ndel1. Dynein motility is stimulated by (i) pharmacological and genetic inhibition of GSK-3β, (ii) an insulin-sensitizing agent (rosiglitazone) and (iii) manipulating an insulin response pathway that leads to GSK-3β inactivation. Thus, our study connects a well-characterized insulin-signaling pathway directly to dynein stimulation via GSK-3 inhibition.

Indexed as

Amino Acid SequenceAnimalsBinding SitesCarrier ProteinsCell Line, TumorChlorocebus aethiopsCOS CellsCytoplasmDyneinsGlycogen Synthase Kinase 3HumansInsulinMiceMolecular Sequence DataProtein BindingProtein TransportCarrier ProteinsDyneinsGlycogen Synthase Kinase 3InsulinNdel1 protein, mouseaxon transportcentrosomecytoplasmic dyneininsulinNdel1/Nde1retrograde transport

Identifiers

PMID26010407
PMCPMC4543430
OpenAlexW1955309278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.